Productoverview
- NameNBQXdisodiumsalt
- ShortdescriptionPotent,selective,competitiveAMPAreceptorantagoNIST.Disodiumsalt.
- BIOLOGicaldescription
Potent,selectiveandcompetitiveAMPAreceptorantagonist.Alsokainatereceptorantagonist.Watersoluble,disodiumsalt.Showsneuroprotective,antinociceptiveandanticonvulsiveactions.NBQXalsoavailable.
- BiologicalactionAntagonist
- Purity>98%
- Customercomments
Highqualityandaffordable!Weusethiscompoundroutinelyinthelabforneuronalrecordings.Verifiedcustomer,TheUniversityofMontana
Workedjustasitshould,resultsindistinguishablefromourpreviousproductbutatasignificantcostreduction!Verifiedcustomer,TheUniversityofToronto
Goodqualityandgreatprice!Verifiedcustomer,TheUniversityofNewcastle
NBQXdisodiumsaltproducedbyHelloBioproducedaverypotentand"clean"blockofsynapticAMPAcurrents,withnoeffectonotherGABAAorNMDAreceptors.Verifiedcustomer,TheUniversityofEdinburgh
- Ourproductsinaction2citationsSubmitYourCitationNow
Images
Properties
- Chemicalname2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamidedisodiumsalt
- MolecularWeight380.24
- Chemicalstructure
- MolecularFormulaC12H6N4Na2O6S
- CASNumber479347-86-9
- PubChemidentifier3272523
- SMILES[Na+].[Na+].NS(=O)(=O)c3cccc2c3c(cc1nc([O-])c([O-])nc12)[N+]([O-])=O
- SourceSynthetic
- InChiInChI=1S/C12H8N4O6S.2Na/c13-23(21,22)8-3-1-2-5-9(8)7(16(19)20)4-6-10(5)15-12(18)11(17)14-6;;/h1-4H,(H,14,17)(H,15,18)(H2,13,21,22);;/q;2*+1/p-2
- InChiKeySVJKYIUJRJEABK-UHFFFAOYSA-L
- MDLnumberMFCD12910445
- AppearanceOrangesolid
Applications
- Applicationnotes
TheAMPAreceptorantagonistNBQXdisodiumsaltinhibitstheactionsofglutamatebyactingatAMPARsandiscommonlyusedat10μM.NBQXdisodiumsaltfromHelloBioinhibitsspontaneousandevokedexcitatorypostsynapticcurrents(EPSCs)(seeFig1above).CompleteAMPAreceptorblockadewasachievedat10μMandNBQXdisodiumsaltwasalsoeffectiveatreducingthesecurrentsat1μM.
#Protocol1:Evokedandspontaneousexcitatorypostsynapticcurrents(EPSCs)
- WholecellvoltageclamprecordingswereobtainedfromlayerVneuronsofthemouseprelimbiccortexbrainslice.
- EPSCswereevokedviaastimulatingelectrodeplacedinlayersII/IIIdeliveringasinglesquare(150μs)pulseevery10secatanintensitythatgaveareliableEPSC.
- Neuronswereheldat-70to-60mV(thereversalpotentialofGABAcurrents).EPSCswerecontinuouslystimulatedandrecordedinresponseto5minapplicationsofvaryingconcentrationsofNBQXdisodiumsaltuntilcompletereceptorinhibition.
- SpontaneousEPSCswererecordedbeforeandafteradditionofNBQXdisodiumsaltbyholdingtheneuronat-70mVandrecordingfor10sec.
- RecordingsforEPSCsweremadeintheabsenceofGABAA-Rantagonists.
StoringandUsingYourProduct
- Storageinstructions-20°C
- SolubilityoverviewSolubleinwater(100mM)
- ImportantThisproductisforRESEARCHUSEONLYandisnotintendedfortherapeuticordiagnosticuse.Notforhumanorveterinaryuse.
ReferencesforNBQXdisodiumsalt
ItisAMPAreceptor,notkainatereceptor,thatcontributestotheNBQX-inducedantinociceptioninthespinalcordofrats.
KongLLetal(2006)BrainRes1100(1):73-7.PubMedID:16777075CompetitiveinhibitionbyNBQXofkainate/AMPAreceptorcurrentsandexcitatorysynapticpotentials:importanceof6-nitrosubstitution.
RandleJCetal(1992)EurJPharmacol215(2-3):237-44.PubMedID:1382998BothMK801andNBQXreducetheneuronaldamageafterimpact-accelerationbraininjury.
GodaMetal(2002)JNeurotrauma19(11):1445-56.PubMedID:12490009AntiepileptogenicandanticonvulsanteffectsofNBQX,aselectiveAMPAreceptorantagonist,intheratkindlingmodelofepilepsy.
NambaTetal(1994)BrainRes638(1-2):36-44.PubMedID:8199874Pharmacologicalcharacterizationofglutamatergicagonistsandantagonistsatrecombinanthumanhomomericandheteromerickainatereceptorsinvitro.
Altetal(2004)Neuropharmacology46(6):793-806PubMedID:15033339